510(k) Report

510(k) · Cleared

Cleared

FREND PSA PLUS (reagent cartridge)

K162378510(k) TraditionalCleared May 17, 2017266-day reviewClass II21 CFR 866.6010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nanoentek USA, Inc. · LTJ Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

Cleared on May 17, 2017 as substantially equivalent to K124056 (Nanoentek, Inc., 2013) after a 266-day review. Its family tree reaches back 2 generations to 1993.

Decided
May 17, 2017
Review
266 days
Class
Class II
Product code
LTJ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to P910065 (1993). No later device cites it as a predicate yet.

  1. Root · 2 generations backP910065 Aia-Pack PsaTosoh Bioscience, Inc. · 1993 · Recalled
  2. 1 generation backK124056 Frend Psa Plus (Reagent Cartridge)Nanoentek, Inc. · 2013
  3. This deviceK162378 FREND PSA PLUS (reagent cartridge)Nanoentek USA, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2P910065Aia-Pack PsaTosoh Bioscience, Inc.19931
−1K124056Frend Psa Plus (Reagent Cartridge)Nanoentek, Inc.2013—
0 (this device)K162378FREND PSA PLUS (reagent cartridge)Nanoentek USA, Inc.2017—
FIG. 1 — Lineage of K162378, 1993–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LTJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LTJ device

  1. #1 K251630 Atellica IM Total PSA II (tPSAII)score 10.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K124056Frend Psa Plus (Reagent Cartridge)
Summary page 6
…ges  30 Disposable pipette tips  1 FREND™ PSA Plus Code Chip  1 FREND™ PSA Plus Package Insert The FREND™ System (previously cleared in K124056, K131928, K152422, K153577, and K162754) is not provided with the kit but is required for the use of the FRENDTM PSA Plus test ca…
Nanoentek, Inc.2013—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 19.9 years on median.
  • 1 of the 2 ancestors has a recall of any class.

How does its category compare?

All LTJ devices

LTJ Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · LTJ

3in 2025

2013: 12016: 22017: 102018: 72019: 22020: 12021: 22023: 22024: 32025: 32026 (partial year): 3
2007high 10 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LTJ

Too few LTJ 510(k)s in any year since 2007 to give a median.

Recalls per year · LTJ

1in 2025

2008: 32010: 22013: 12025: 1
2007high 3 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LTJ

14in 2025

2007: 172008: 572009: 582010: 342011: 1092012: 1012013: 692014: 192015: 142016: 82017: 132018: 82019: 112020: 42021: 82022: 112023: 172024: 82025: 14
2007high 109 (2011) · low 4 (2020)2025

MAUDE reports naming product code LTJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—017
20080—357
20090—058
20100—234
20110—0109
20120—0101
20131—169
20140—019
20150—014
20162—08
201710—013
20187—08
20192—011
20201—04
20212—08
20220—011
20232—017
20243—08
20253—114
20263—0—

What is it indicated for?

The NanoEnTek FREND™PSA Plus is designed for in vitro DIAGNOSTIC USE ONLY for the quantitative measurement of total Prostate Specific Antigen (PSA) in human serum, Li-heparinized plasma, and K3-EDTA plasma using the FREND™ System. This device is indicated for the serial measurement of total PSA to be used as an aid in the management of patients with prostate cancer.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K162378: FREND PSA PLUS (reagent cartridge).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162378

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026